Cannabis Freedom Index
← History

Medical 🇸🇬 Singapore

Singapore allows its first patient to use a cannabis-derived medicine

In December 2019 a girl with drug-resistant epilepsy became the first patient approved to receive an unregistered cannabinoid through a doctor’s named-patient application. The approval was patient-specific and exceptional; there was no general medical-cannabis programme, pharmacy supply or registered product.[1][2]

Listed for context. No score change is recorded for Singapore here.

References

  1. Singapore MHA/MOH — Position on pharmaceutical products containing cannabinoids (13 February 2019)Registered cannabinoid pharmaceuticals and named-patient import approval.archived
  2. The Straits Times — First Singapore case of cannabis-derived medication allowed (1 December 2019)Girl with drug-resistant epilepsy; named-patient approval.archived

Checked. The date and the event were compared with a source that was read.

    ↑↓ to move, ↵ to open.